反应 #1483116
ord-ad58bda64d674ce1aa41b2fa12c6883f
反应方程式
试剂
反应条件
后处理
- 1workup.ADDITIONadded to the polymer solution
- 2其他yielding a milky suspension as the organic phase
- 3其他to provide an emulsion
- 4其他The emulsion was collected directly into a 10 mM sodium phosphate (pH 8, 0° C., 150 mL) solvent extraction solution
- 5萃取to extract EtOAc
- 6过滤Hardened microparticles were collected by filtration
- 7洗涤washed with water, air
- 8其他dried
- 9其他stored at 4° C
实验过程
PLGA polymer (MW 13,000, 180 mg) was dissolved in EtOAc (900 μL). Oxytocin acetate (20 mg) was dissolved in MeOH (100 μL) and added to the polymer solution yielding a milky suspension as the organic phase. The resulting organic phase was combined with a 1% PVA aqueous phase containing 5% EtOAc to provide an emulsion. The emulsion was collected directly into a 10 mM sodium phosphate (pH 8, 0° C., 150 mL) solvent extraction solution and stirred for four hours while warming to room temperature to extract EtOAc. Hardened microparticles were collected by filtration, washed with water, air dried and stored at 4° C. This provided formulation BL (143 mg, 71.5% yield) with a median particle size 44.0 μm. The core load (1.67%), encapsulation efficiency (16.7%) and in vitro burst (46.3%) were determined by RP-HPLC assay.